Results 21 to 30 of about 8,261 (192)
VaccinesThe SARS-CoV-2 Omicron variant and its sublineages continue to cause COVID-19-associated pediatric hospitalizations, severe disease, and death globally. BNT162b2 and CoronaVac are the main vaccines used in Chile.
Diego A. Díaz-Dinamarca +15 more
doaj +2 more sources
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
Vaccines, 2023 Immune responses after COVID-19 vaccination should be evaluated in different populations around the world. This study compared antibody responses induced by ChAdOx1 nCoV-19, CoronaVac, and BNT162b2 vaccines.
Letícia Carrijo Masson +10 more
doaj +2 more sources
Vaccines, 2022 Coronavirus disease 2019 (COVID-19) continues to pose a threat to public health with the potential for the emergence of new variants. Vaccines are the milestones to control and slow down the damage of the pandemic.
Meliha Cagla Sonmezer +9 more
doaj +2 more sources
Human Vaccines & Immunotherapeutics, 2022 CoronaVac, also known as the Sinovac inactivated SARS-CoV-2 vaccine, has been widely implemented in combating the COVID-19 pandemic. We summarized the results of clinical trials and real-world studies of CoronaVac in this review. The overall efficacy for
Lairun Jin +4 more
doaj +2 more sources
Vaccines, 2023 Previous reports have shown that heterologous boosting with the AD5-vectored COVID-19 vaccine Convidecia based on a primary series of two doses of inactivated vaccine induces increasing immune responses.
Hudachuan Jiang +9 more
doaj +2 more sources
Booster mRNA Vaccination Prevents Breakthrough Severe COVID-19 Infections. [PDF]
J Med VirolABSTRACT This study aimed to assess the humoral immune response following administration of a BNT162b2 mRNA COVID‐19 booster dose and to evaluate its association with the development of SARS‐CoV‐2 infection after vaccination. Between July 2021 and February 2022, serum samples were collected from 313 individuals 28 days after receiving a COVID‐19 ...
Dinç HÖ +12 more
europepmc +2 more sources
Strength and durability of antibody responses to BNT162b2 and CoronaVac [PDF]
Vaccine, 2022 ABSTRACT We studied 2780 adults in Hong Kong who received CoronaVac inactivated virus vaccine (Sinovac) and BNT162b2 mRNA vaccine (“Comirnaty”, BioNTech/Fosun Pharma). We found stronger and more durable antibody responses to two doses of the mRNA vaccine, and slightly stronger initial antibody responses to each vaccine in younger adults
Benjamin J. Cowling +12 more
openaire +2 more sources
A RCT of a third dose CoronaVac or BNT162b2 vaccine in adults with two doses of CoronaVac [PDF]
, 2021 Abstract Background Poor immunogenicity and antibody waning were found in vaccinees of CoronaVac. There is lack of randomized controlled trial (RCT) data to compare the immunogenicity and safety of schedules using homologous and heterologous vaccine as a booster dose.
Chris Ka Pun Mok +10 more
openaire +1 more source
Effect of Pfizer/BioNTech and Sinovac/CoronaVac Vaccines on Semen Parameters in Infertile Patients with Idiopathic Infertility: A Single-center Cohort Study [PDF]
, 2023 Objective:We investigated the effects of Coronavirus disease-2019 (COVID-19) vaccines on semen parameters in patients with idiopathic infertility who visited our urology clinic.Materials and Methods:Patients who visited our andrology clinic between ...
Dil, Eyüp, Eyüp Dil
core +1 more source
Human Vaccines & Immunotherapeutics, 2022 Protective neutralizing antibody titers reduce in time after COVID-19 vaccinations, as in individuals who have had COVID-19. This study aimed to evaluate the safety and immunogenicity of CoronaVac and TURKOVAC vaccines used as a booster dose after ...
Ahmet Omma +20 more
doaj +1 more source